BridgeMD
New treatment option for Cancer
Official title Therapeutic Play on Pain Tolerance and Emotion Regulation in Children
ClinicalTrials.gov ID: NCT06368947
What this study is testing
- What it's testing
- The research is a randomized controlled experimental study. The population of the research will consist of 10-18 year old children who were diagnosed with acute lymphoblastic leukemia and received chemotherapy, who were admitted to the Children's Hematology Clinic of Adana City Training and Research Hospital between 19.05.2024 and 19.05.2025.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 18. Healthy volunteers may be eligible.
You may be able to join if
- Between the ages of 10-18
- Diagnosed with acute lymphoblastic leukemia
- Those receiving chemotherapy treatment
- Children who do not have a chronic disease other than the diagnosis of the disease in question
You likely can't join if
- Under 10 years of age or over 18 years of age
- Diagnosed other than acute lymphoblastic leukemia
- Not receiving chemotherapy treatment
- Children with chronic diseases other than the diagnosis of the disease in question
The study team makes the final eligibility decision.
Where it's taking place
- Erzurum, Erzurum, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erzurum, Erzurum, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.